chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5/1/09 Patient received immunization at 11:00 and then developed hives that afternoon, no respiratory distress, gave patient Benadryl. Claritin, and Orapred, doing well currently.
This spontaneous report as received from a Registered Nurse refers to unspecified number of patients. The nurse reported that another office was improperly storing RECOMBIVAX HB during the months of February 2013, March 2013 and April 2013. It was reported that there was a possibility that the vaccine was administered to an unspecified number of patients. No symptoms were reported. This is one of several reports from the same source. Additional information has been requested.
Headache, Myalgia, NauseaVomiting, SORE ARM/CHILLS Narrative:
1/31/19 Started with chills, fatigue, aches and nausea. Patient states she did nothing and symptoms improved by 02/02/2019. 02/05/2019 Patient has rash left upper arm getting worse. Saw MD today. Has Erythema Multiforme. Advised BENADRYL. May need steroids.
Fever started approximately 24 hours after receiving shots. Lasted 3 days. Took back to doctors office and they recommended to continue alternating Tylenol and ibuprofen.
After getting my booster, I was watching football one evening and noticed a large amount of large hives on my body and it began to be itchy. This kept happening. I went to my doctor and we really could not find a reason for these hives. I have seen a dermatologist and am not seeing an integrative health specialist. I have gotten to the point where I have to be on an antihistamine other wise I am breaking out in hives mostly in the evening and then its get really itchy. I have co workers who have this happening as well after their vaccine. The thing that we are finding that may cause this is the vaccine. We have tried eliminating foods, shower products, medications, all these things and tests and nothing is coming up as the cause. I cannot even miss a dose of the antihistamine or I am broken out in the hives and itching.
Gave adult dose of Hep A instead of pediatric dose. No signs or symptoms at this time.
afeb, swollen lt leg, fussiness, crying, limp when wlaking;no tx;
On May 5th, 2021 at 10:45 am I experienced severe dizziness and faintness. I was unable to ride from a laying position without passing out. When I would try to sit up my heart rate would go from the low 60s to 120-130 before I would faint. This condition was persistent for 4 hours and my parents made the decision for me to go to the emergency room.  At the Er they administered fluids and observed me for about 4 hours and then sent me home because I could stand and walk. They also determined that I was somewhat anemic, my hemoglobin was 9.6.   In the weeks following these visits I had a number of episodes these episodes including symptoms of heart palpitations, tingly hands, and feet, mouth, and chin going numb,  feeling faint and dizzy eyes, and other visual disturbances. One of these episodes occurred on June 12th, 2021 while I was driving. I felt heart palpitations, tingly hands, and feet, face and chin going numb and feeling faint. I pulled over which happened to be in a parking lot where there was an Er. I went in and got evaluated. They ran an EKG but felt they did not catch whatever the episode was so they prescribed me a portable heart monitor. Which I wore for 14 days and am now waiting for the results.
Left facial numbness; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Left facial numbness) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced HYPOAESTHESIA (Left facial numbness). On 21-Jan-2021, HYPOAESTHESIA (Left facial numbness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant or treatment information was provided.   This case was linked to MOD-2021-049556 (Patient Link).
headaches; pain on his body; pain on the arm where he was injected; A spontaneous case was received from the consumer concerning male patient of 70 years who received Moderna's  COVID-19 vaccine and experienced  headaches/Headache, pain on his body/ Pain, pain on the arm where he was injected/ Injection site pain.  The patient's medical history was not provided. No relevant concomitant medications was reported.  On 18-Jan-2021 prior to the onset of the events, the patient received first of the two planned doses of mRNA-1273 in arm for the prophylaxis of COVID-19 infection.  On 18-Jan-2021 the patient experienced headaches, pain on his body and pain on the arm where he was injected.  Action taken with the second dose of mRNA-1273 in response to the event was not reported.  The outcome of the events, injection headaches/Headache, pain on his body/ Pain, pain on the arm where he was injected/ Injection site pain, was not provided.
This spontaneous report as received from a medical assistant refers to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, drug reaction or allergies and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with improperly stored doses of PROQUAD (lot # M042498, expiry date: 17-APR-2018 and lot # N009773, expiry date: 20-SEP-2018) for prophylaxis reconstituted with properly stored sterile diluent (lot # and expiry date unknown). Dosing details and route of administration were not reported. On an unknown date, the vaccine was exposed to temperature of 5.2 F for 30 minutes. No adverse effects reported. No previous temperature excursions occurred. This case was reported because of a data logger. No product quality complaint (PQC) was reported. No further information to report. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1708USA012627.
On or about March  5th or 6th I started noticing my heart was beating rapidly and my blood pressure was higher.  Mostly at night but it happened again this morning. Feeling like I might get a headache but don?t get one. Started thinking it might be a reaction to the shot. Unsure whether to get second dose .
Got really sick; This case was reported by a consumer via call center representative and described the occurrence of sickness in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (first dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.     Additional Information: GSK Receipt Date: 06-Feb-2023: Reporter's Comment: The reporter was the patient's sister-in-law. The patient received the second dose. The reporter listed to the recording and this was word for word what she said. The reporter reported that, the patient (sister in law) was little bit older than reporter. The reporter had the same, had the exact, it was like clockwork. The patient had the exact same second shot that it was a little bit worse but was delayed like 10 hours.  The reporter said to patient that like at 10:00  you would going to get really sick. The reporter told her that would have to file a report on her sister in law's experience and asked if  could ask a few questions and she declined. This case had been linked with US2023AMR018964, US2023AMR018960 same reporter.; Sender's Comments:  US-GSK-US2023AMR018964:Same reporter US-GSK-US2023AMR018960:Same reporter
pain in back of legs and arms; fatigue; diarrhea; knot in my stomach; This spontaneous case was reported by a consumer and describes the occurrence of STOMACH MASS (knot in my stomach), DIARRHOEA (diarrhea), FATIGUE (fatigue) and PAIN IN EXTREMITY (pain in back of legs and arms) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced STOMACH MASS (knot in my stomach). On 03-Feb-2021, the patient experienced DIARRHOEA (diarrhea) and FATIGUE (fatigue). On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in back of legs and arms). On 06-Feb-2021, PAIN IN EXTREMITY (pain in back of legs and arms) had resolved. At the time of the report, STOMACH MASS (knot in my stomach), DIARRHOEA (diarrhea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Hive looking rash appeared on torso, by the next day it had spread from head to toe, including his cheeks, hands, feet, and bottom areas. He also began throwing up (2x day), had 4 diarrheas each day for 5 days straight, and has a croupy sounding coughing (water eyes and nose). Just plain miserable! He has had this for 8 days and it's just getting worse.
The patient received their 1st dose of Pfizer COVID vaccine and was sitting in a chair for the 15 minute observation period. A few minutes after receiving the vaccine, the patient witnessed another patient fall to the floor, which caused her to get anxious. Patient began getting nauseous, and vomited several times. Patient was given some water and an orange to eat. 911 was called and paramedics assessed the patient. Patient was also very sweaty. Paramedics stayed with the patient for awhile, and patient left on her own some time later
Flushing; BP 147/97 (pulse 100), 97% O2 sat. Water and crackers given.
her mouth hurts and had swelling; her mouth hurts and had swelling; swollen face; puffy lips; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program, spontaneous. This 37-year-old female patient received 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose via an unknown route on 09Aug2021 at 37-year-old for Covid-19 immunization. Medical history included broken tooth. Concomitant drug were not provided. She had a broken tooth and asked "If you have an infection in the body will the vaccine make it worst?". Few minutes after her 1st dose her mouth hurts and had swelling. She woke up the next morning with swollen face and puffy lips. It was further reported that went on Monday to get her vaccine and received her first dose. Instantly her mouth started hurting. Hours later, her mouth and left side of face started swelling up.  She researched everything and did not find that if a person had a broken tooth prior to the COVID Vaccine, that person should not get the vaccine. The 2nd dose would be on 30Aug2021. Outcome of the events was unknown.     The lot number for BNT162B2 was not provided and will be requested during follow up.
Notified by patient's co-worker that patient had passed away. 12/15/09 Death Certificate received. DOD 12/08/2009. Cause of Death: Myocardial Infaction. Atherosclerotic Coronary Vascular Disease.
Dermatitis; Funny taste in mouth, food does not taste right; sore arm; rashes on bottom of both legs; This spontaneous case was reported by a consumer and describes the occurrence of DERMATITIS (Dermatitis), TASTE DISORDER (Funny taste in mouth, food does not taste right), PAIN IN EXTREMITY (sore arm) and RASH (rashes on bottom of both legs) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027C21A and 040A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMINS NOS for an unknown indication.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DERMATITIS (Dermatitis), TASTE DISORDER (Funny taste in mouth, food does not taste right), PAIN IN EXTREMITY (sore arm) and RASH (rashes on bottom of both legs). At the time of the report, DERMATITIS (Dermatitis), PAIN IN EXTREMITY (sore arm) and RASH (rashes on bottom of both legs) outcome was unknown and TASTE DISORDER (Funny taste in mouth, food does not taste right) had not resolved.            Treatment information was not reported.
Shortness of breath; Severe chest pressure; This is a spontaneous report from a contactable consumer. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single for COVID-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. The patient experienced severe chest pressure and shortness of breath after 8-10 days post vaccination on an unspecified date. The outcome of the events was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021739776 same reporter/drug/AE, different patient
Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose Pfizer 03/24/2021 Lot# ER8727. 2nd dose: Pfizer 04/14/2021 Lot# EW0150. Diagnosed COVID positive: 06/24/2021. Exposure: Home. Symptoms: Headache.
Whole left arm hurt Severe headache 104.5 fever Passed out 2 different times Chills Delerious Lost control of bladder twice Seizure Breathing difficulties-responded to use of inhaler
felt tired and achy; felt tired and achy; alopecia areata; This spontaneous case was reported by a patient and describes the occurrence of ALOPECIA AREATA (alopecia areata), PAIN (felt tired and achy) and FATIGUE (felt tired and achy) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 03-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 08-Jun-2023,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ALOPECIA AREATA (alopecia areata). On an unknown date, the patient experienced PAIN (felt tired and achy) and FATIGUE (felt tired and achy). At the time of the report, ALOPECIA AREATA (alopecia areata), PAIN (felt tired and achy) and FATIGUE (felt tired and achy) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported. It was reported that the patient had received the 1st dose of Covid-19 vaccine in the left. The patient had no adverse reactions after taking the second dose. On 8-Jun-2023, the patient started losing hair. The patient went to primary physician and dermatologist and they both confirmed it as Alopecia Areata. No treatment medication was reported.
Patient was sitting in observation and complained of feeling light-headed. Taken to EMS room. After lying down and eating a snack, states she feels much better.
IMMTRAC INDICATES THIRD DOSE OF UNKNOWN COVID VACCINE ADMINISTERED, FOLLOWING 04/27/2021
Information has been received from a nurse practitioner concerning a 12 month old male with no pertinent medical history, drug reactions or allergies who on 27-OCT-2007 was vaccinated subcutaneously with 0.5 mL of varicella virus vaccine live (Oka/Merck) (lot # 658374/1117U). Concomitant therapy included influenza virus vaccine (unspecified) and Prevnar. On 12-NOV-2007, the patient developed redness, local heat and swelling at injection site. The patient recovered from the redness, local heat and swelling at the injection site on an unspecified date. Unspecified medical attention was sought. There was no product quality complaint. There was no lab diagnostic studies performed. Additional information is not expected.
Massive headache across the top of my head starting one week after first (only) shot. Headache lasted 2 weeks fro March 13 to March 27.
Severe abdominal pain and cramping for hours. From about 12:30pm to 2am. Self-administered activated charcoal around 2am.
30APR lt shoulder & neck pain;2MAY bilat upper & lower extremity weakness;3MAY adm w/acute cervical spinal cord synd which has progressed rapidly to severe quadriparesis; pt discharged to another care facility. A follow up report received 6/7/2000 adds: Pt is still doing physical therapy and is slowly improving. Her rehab records are already in our files.
Symptoms started the evening of the vaccine: Facial numbness-cheeks, severe headache, runny nose, congestion, vomiting, chills, fevers, scalp soreness, muscle aches. Started taking 2 (500mg) Tylenol around the clock for symptom management without much relief.
back pain with 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain with 2nd dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (back pain with 2nd dose). At the time of the report, BACK PAIN (back pain with 2nd dose) outcome was unknown.            No concomitant medications were reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow-up received and contains non-significant information- updated race information; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the event, a causal relationship cannot be excluded.
Always get a cold afterward; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 07-Dec-2020.  This case involves a patient of unknown demographics who always got the flu (influenza), while the patient received Influenza Vaccine.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medication was unknown.  On an unknown date, the patients received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, the patient stated that he/she always get a cold afterward. He/she had been that way for years.  It was not reported if the patient received a corrective treatment. Outcome of the event was unknown, at the time of reporting. There will be no information available on the batch number for this case.
Rash; This case was reported by a other health professional and described the occurrence of rash in a 79-year-old female patient who received Herpes zoster (Shingrix) (batch number 4S37J, expiry date 23rd November 2023) for prophylaxis.   Concurrent medical conditions included hypothyroidism. Concomitant products included levothyroxine.   On 5th January 2023, the patient received Shingrix (intramuscular). On 8th January 2023, 3 days after receiving Shingrix, the patient experienced rash (serious criteria clinically significant/intervention required). On an unknown date, the outcome of the rash was not recovered/not resolved.   It was unknown if the reporter considered the rash to be related to Shingrix.  Linked case(s) involving the same patient:US2023AMR017246   Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's comments: The reporter had reported that the patient had experienced rash after receiving the Shingrix vaccine. The reporter had reported the seriousness for rash as intervention required. The reporter had consented to follow-up.; Sender's Comments:  US-GSK-US2023AMR017246:Same report, Pharma case.
Patient noted numbness and paresthesia in the left arm and leg shortly after vaccine. Symptoms stable to improving presently.
This spontaneous report was received from a physician via a company representative referring to a 23 year old non pregnant female patient. No information regarding the patient's medical history, concurrent conditions, previously drug reactions, allergies, or concomitant therapies was unknown by the reporter. On an unspecified date in June 2011, the patient was vaccinated with the first dose of GARDASIL (strength, route, anatomical location, lot number and expiration date were not provided) for prophylaxis, then on unspecified date in June 2014, the patient received the second dose of GARDASIL (strength, route, anatomical location, lot number and expiration date were not provided) for prophylaxis. On unspecified date, the patient experienced unspecified adverse event which required a unspecified stent placement. At the time of the report, the outcome of adverse event was not provided. The reporter did not assess the relatedness between the event and suspect therapy. Upon internal review, the adverse event was considered to be medical significant since stent placement was required.
Notified by Moderna/Health Department that vaccine may have been expired by 4 days.
18-year-old who received her prophylactic 3-dose rabies vaccine series on January 21, January 28, and February 11, 2004. She was notified by the immunization clinic at on April 21, 2004 that THE LOT SHE RECEIVED HAD BEEN RECALLED AND SHE NEEDED TO RETURN TO THE CLINIC TO RECEIVE 2 ADDITIONAL DOSES. She voiced concern because when she received the other doses she became ill. She reports that she developed body aches, weakness, headache, nausea, and chills. These symptoms developed within three hours of receiving the immunization and lasted approximately 36 hours. She denies vomiting.
Felt a swollen, painful lymph node in left arm pit exactly a week after receiving the first dose of Moderna (April 13). Next day, swollen, red lump at infection site. The swelling and redness resolved at the injection site; however, lymph node pain spread to right armpit, and into both lymphs in the neck. These have persisted for a week so far. Also experiencing pain in joints at elbow, some numbness and tingling in the hands (mostly left hand). Mild headache, mild nausea after eating.
Vaccine administered after use by date. Efficacy study done by Modera and vaccine deemed effective and no re-vaccination needed.
Pfizer-BioNTech COVID-19 Vaccine EUA: immediately after receiving vaccination patient reported dizziness, tremors, diaphoresis, and numbness and tingling of legs. Medical emergency team called to evaluate patient. Vital signs checked four times throughout observation period and all were within normal ranges. Patient's symptoms improved with food and juice and able to leave vaccine clinic for home asymptomatic and stable.